These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
257 related articles for article (PubMed ID: 15330172)
21. Dihydroartemisinin is cytotoxic to papillomavirus-expressing epithelial cells in vitro and in vivo. Disbrow GL; Baege AC; Kierpiec KA; Yuan H; Centeno JA; Thibodeaux CA; Hartmann D; Schlegel R Cancer Res; 2005 Dec; 65(23):10854-61. PubMed ID: 16322232 [TBL] [Abstract][Full Text] [Related]
22. Molecular pharmacology and pharmacogenomics of artemisinin and its derivatives in cancer cells. Efferth T Curr Drug Targets; 2006 Apr; 7(4):407-21. PubMed ID: 16611029 [TBL] [Abstract][Full Text] [Related]
23. Dihydroartemisinin improves the efficiency of chemotherapeutics in lung carcinomas in vivo and inhibits murine Lewis lung carcinoma cell line growth in vitro. Zhou HJ; Zhang JL; Li A; Wang Z; Lou XE Cancer Chemother Pharmacol; 2010 May; 66(1):21-9. PubMed ID: 19756601 [TBL] [Abstract][Full Text] [Related]
24. Cytotoxic activity of secondary metabolites derived from Artemisia annua L. towards cancer cells in comparison to its designated active constituent artemisinin. Efferth T; Herrmann F; Tahrani A; Wink M Phytomedicine; 2011 Aug; 18(11):959-69. PubMed ID: 21831619 [TBL] [Abstract][Full Text] [Related]
25. Preparation, characterization and in vitro efficacy of magnetic nanoliposomes containing the artemisinin and transferrin. Gharib A; Faezizadeh Z; Mesbah-Namin SA; Saravani R Daru; 2014 May; 22(1):44. PubMed ID: 24887240 [TBL] [Abstract][Full Text] [Related]
26. Artemisinin-transferrin conjugate retards growth of breast tumors in the rat. Lai H; Nakase I; Lacoste E; Singh NP; Sasaki T Anticancer Res; 2009 Oct; 29(10):3807-10. PubMed ID: 19846912 [TBL] [Abstract][Full Text] [Related]
27. Dihydroartemisinin induces apoptosis and inhibits proliferation, migration, and invasion in epithelial ovarian cancer via inhibition of the hedgehog signaling pathway. Liu Y; Gao S; Zhu J; Zheng Y; Zhang H; Sun H Cancer Med; 2018 Nov; 7(11):5704-5715. PubMed ID: 30338663 [TBL] [Abstract][Full Text] [Related]
28. Mechanisms of Dihydroartemisinin and Dihydroartemisinin/Holotransferrin Cytotoxicity in T-Cell Lymphoma Cells. Wang Q; Wu S; Zhao X; Zhao C; Zhao H; Huo L PLoS One; 2015; 10(10):e0137331. PubMed ID: 26502166 [TBL] [Abstract][Full Text] [Related]
29. Stability of artemisinin in aqueous environments: impact on its cytotoxic action to Ehrlich ascites tumour cells. Beekman AC; Woerdenbag HJ; Van Uden W; Pras N; Konings AW; Wikström HV J Pharm Pharmacol; 1997 Dec; 49(12):1254-8. PubMed ID: 9466353 [TBL] [Abstract][Full Text] [Related]
30. Oral artemisinin prevents and delays the development of 7,12-dimethylbenz[a]anthracene (DMBA)-induced breast cancer in the rat. Lai H; Singh NP Cancer Lett; 2006 Jan; 231(1):43-8. PubMed ID: 16356830 [TBL] [Abstract][Full Text] [Related]
31. Targeted treatment of cancer with artemisinin and artemisinin-tagged iron-carrying compounds. Lai H; Sasaki T; Singh NP Expert Opin Ther Targets; 2005 Oct; 9(5):995-1007. PubMed ID: 16185154 [TBL] [Abstract][Full Text] [Related]
32. Effects of antioxidants and pro-oxidants on cytotoxicity of dihydroartemisinin to Molt-4 human leukemia cells. Gerhardt T; Jones R; Park J; Lu R; Chan HW; Fang Q; Singh N; Lai H Anticancer Res; 2015 Apr; 35(4):1867-71. PubMed ID: 25862840 [TBL] [Abstract][Full Text] [Related]
33. Biological activity of dihydroartemisinin in canine osteosarcoma cell lines. Hosoya K; Murahari S; Laio A; London CA; Couto CG; Kisseberth WC Am J Vet Res; 2008 Apr; 69(4):519-26. PubMed ID: 18380584 [TBL] [Abstract][Full Text] [Related]
34. Antitumor activity of an Artemisia annua herbal preparation and identification of active ingredients. Lang SJ; Schmiech M; Hafner S; Paetz C; Steinborn C; Huber R; Gaafary ME; Werner K; Schmidt CQ; Syrovets T; Simmet T Phytomedicine; 2019 Sep; 62():152962. PubMed ID: 31132755 [TBL] [Abstract][Full Text] [Related]
35. Enhanced apoptotic effects of dihydroartemisinin-aggregated gelatin and hyaluronan nanoparticles on human lung cancer cells. Sun Q; Teong B; Chen IF; Chang SJ; Gao J; Kuo SM J Biomed Mater Res B Appl Biomater; 2014 Apr; 102(3):455-62. PubMed ID: 24039154 [TBL] [Abstract][Full Text] [Related]
36. Synthesis and anti-cancer activity of covalent conjugates of artemisinin and a transferrin-receptor targeting peptide. Oh S; Kim BJ; Singh NP; Lai H; Sasaki T Cancer Lett; 2009 Feb; 274(1):33-9. PubMed ID: 18838215 [TBL] [Abstract][Full Text] [Related]
37. Dihydroartemisinin accentuates the anti-tumor effects of photodynamic therapy via inactivation of NF-κB in Eca109 and Ec9706 esophageal cancer cells. Li YJ; Zhou JH; Du XX; Jia de X; Wu CL; Huang P; Han Y; Sui H; Wei XL; Liu L; Yuan HH; Zhang TT; Zhang WJ; Xie R; Lang XH; Liu T; Jiang CL; Wang LY; Bai YX Cell Physiol Biochem; 2014; 33(5):1527-36. PubMed ID: 24854841 [TBL] [Abstract][Full Text] [Related]
38. Antiviral effect of artemisinin from Artemisia annua against a model member of the Flaviviridae family, the bovine viral diarrhoea virus (BVDV). Romero MR; Serrano MA; Vallejo M; Efferth T; Alvarez M; Marin JJ Planta Med; 2006 Oct; 72(13):1169-74. PubMed ID: 16902856 [TBL] [Abstract][Full Text] [Related]
39. Dihydroartemisinin induced caspase-dependent apoptosis through inhibiting the specificity protein 1 pathway in hepatocellular carcinoma SK-Hep-1 cells. Im E; Yeo C; Lee HJ; Lee EO Life Sci; 2018 Jan; 192():286-292. PubMed ID: 29128513 [TBL] [Abstract][Full Text] [Related]
40. [Apoptosis of nasopharyngeal carcinoma cells line CNE-2 induced by dihydroartemisinin and its possible mechanism]. Huang Z; Zhang Y; Jiang D; Huang X; Huang B; Luo G Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Jul; 27(13):717-20. PubMed ID: 24073581 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]